Health ❯ Healthcare ❯ Clinical Trials

Vaccine Trials

Efficacy Studies Triple-Negative Breast Cancer Allergard Vaccine Trials Lung Cancer Vaccine Participant Recruitment Phase I Trials 21-Valent Vaccine Ovarian Cancer Vaccine Trials Fungal Vaccine Trials Phase III Trials Two-Dose Regimen Moderna Vaccine Safety Monitoring CMV-based Vaccines mRNA Vaccines Phase 3 Trials

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Tougher FDA rules are squeezing efforts to test shots in healthy adults 50 to 64.

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

MCRI Launches World-First Infant Trial of 21‑Valent Pneumococcal Vaccine

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial